RAP valuation is from its disruptive concept and outlook IMO. SP can be anywhere between 30-50c related to how quickly FDA and first deal to land. There’s little doubt about other commerciality follow suit.
Cannot really comment on other particular one but lots of digital health stocks are slow with revenue expansion while fixed cost incurred is huge. In this respect people are more optimistic imagining RAP being $1 with the start of some decent deal
- Forums
- ASX - By Stock
- RAP
- rap chart
rap chart, page-2127
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 2,515 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)